Upexi Inc Revenue Growth Rates (UPXI), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Upexi Inc   (NASDAQ: UPXI)
 

UPXI's Revenue Growth by Quarter and Year

Upexi Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

UPXI Revenue (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter June 3.15
3rd Quarter March 4.56
2nd Quarter December 8.05
1st Quarter September 9.24
FY 25.00

UPXIs Annual Revenue
Upexi Inc 's Revenue in the fiscal year 2026 $ 25.00 millions
Upexi Inc 's Revenue in the fiscal year 2025 $ 15.81 millions
Upexi Inc 's Revenue in the fiscal year 2024 $ 26.00 millions
Upexi Inc 's Revenue in the fiscal year 2023 $ 80.68 millions
Upexi Inc 's Revenue in the fiscal year 2022 $ 44.58 millions




UPXI Revenue fourth quarter 2025 Y/Y Growth Comment
Upexi Inc reported fall in Revenue in the fourth quarter 2025 by -26.59% to $ 3.15 millions, from the same quarter in 2024.
The drop in the fourth quarter 2025 Upexi Inc 's Revenue compares unfavorably to the Company's average Revenue rise of 27.99%.

Looking into fourth quarter 2025 results within Legal Cannabis industry 13 other companies have achieved higher Revenue growth. While Upexi Inc ' s Revenue drop of -26.59% ranks overall at the positon no. 2991 in the fourth quarter 2025.


UPXI Revenue ( Y/Y Growth %) 2025
 2024 2023 2022
4th Quarter June -26.59 % -14.88 % -71.7 % 17.17 %
3rd Quarter March 44.3 % -39.46 % -76.14 % 393.91 %
2nd Quarter December 100.75 % -46.25 % -72.46 % 443.98 %
1st Quarter September 111.93 % -47.28 % -28.46 % 198.71 %
FY   58.02 % -39.13 % -66.82 % -

Financial Statements
Upexi Inc 's fourth quarter 2025 Revenue $ 3.15 millions UPXI's Income Statement
Upexi Inc 's fourth quarter 2024 Revenue $ 4.29 millions Quarterly UPXI's Income Statement


UPXI Revenue (Quarter on Quarter Growth %)

 2025
 2024 2023 2022
4th Quarter June -30.94 % 35.76 % -3.45 % -18.6 %
3rd Quarter March -43.35 % -21.2 % -30.03 % -19.23 %
2nd Quarter December -12.88 % -8.03 % -9.79 % 134.34 %
1st Quarter September 115.38 % -13.49 % -53.57 % -23.95 %
FY (Year on Year)   58.02 % -39.13 % -66.82 % -


Back to UPXI Growth rate Comparisons >> Back to UPXI Growth rate Comparisons >>


Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #14
Consumer Non Cyclical Sector #124
Overall #2991

Revenue Y/Y Growth Statistics
High Average Low
216.5 % 27.99 % -70.58 %
(Mar 31 2023)   (Sep 30 2024)
Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #14
Consumer Non Cyclical Sector #124
Overall #2991
Revenue Y/Y Growth Statistics
High Average Low
216.5 % 27.99 % -70.58 %
(Mar 31 2023)   (Sep 30 2024)

Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Upexi Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
243.28 % 15.48 % -63.64 %
(Jun 30 2022)  


UPXI's IV. Quarter Q/Q Revenue Comment
In the IV. Quarter 2025 Upexi Inc disclosed fall in Revenue from the third quarter by -30.94% to $ 3.15 millions, from $ 4.56 millions achived in the previous reporting period.

Although periodic circumstance commonly energize IV. Quarter 2025 Revenue, this plainly could not be substantial to rescue Legal Cannabis's company achievement, Most analysts pointed out.

Within Legal Cannabis industry 16 other companies have achieved higher Revenue quarter on quarter growth. While Upexi Inc 's Revenue growth quarter on quarter, overall rank is 3496.


Revenue Q/Q Growth Company Ranking
Within: No.
Legal Cannabis Industry #17
Consumer Non Cyclical Sector #145
Overall #3496
Revenue Q/Q Growth Company Ranking
Within: No.
Legal Cannabis Industry #17
Consumer Non Cyclical Sector #145
Overall #3496
Revenue Q/Q Growth Statistics
High Average Low
243.28 % 15.48 % -63.64 %
(Jun 30 2022)  


UPXI's IV. Quarter Q/Q Revenue Comment
In the IV. Quarter 2025 Upexi Inc disclosed fall in Revenue from the third quarter by -30.94% to $ 3.15 millions, from $ 4.56 millions achived in the previous reporting period.

Although periodic circumstance commonly energize IV. Quarter 2025 Revenue, this plainly could not be substantial to rescue Legal Cannabis's company achievement, Most analysts pointed out.

Within Legal Cannabis industry 16 other companies have achieved higher Revenue quarter on quarter growth. While Upexi Inc 's Revenue growth quarter on quarter, overall rank is 3496.


Upexi Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 25.00 $ 26.14 $ 24.74 $ 20.69 $ 15.81
Y / Y Revenue Growth (TTM) 58.1 % 57.81 % 32.84 % -6.28 % -39.19 %
Year on Year Revenue Growth Overall Ranking # 3589 # 3215 # 495 # 2887 # 2498
Seqeuential Revenue Change (TTM) -4.36 % 5.64 % 19.55 % 30.88 % -4.53 %
Seq. Revenue Growth (TTM) Overall Ranking # 2991 # 3132 # 485 # 2908 # 2707


Cumulative Revenue growth Comment
Upexi Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 58.1% year on year, to $ 25 millions if the fiscal year would have ended in Jun 30 2026.
Upexi Inc 's trailing twelve months Revenue growth was higher than company's average 27.99% and higher than 57.81% growth in Mar 31 2026.

In the Consumer Non Cyclical sector 153 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 3215 to 3589.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry # 14
Consumer Non Cyclical Sector # 154
Overall # 3589

Revenue TTM Y/Y Growth Statistics
High Average Low
216.5 %
 27.99 %
-70.58 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 14
Sector # 124
S&P 500 # 2991
Cumulative Revenue growth Comment
Upexi Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 58.1% year on year, to $ 25 millions if the fiscal year would have ended in Jun 30 2026.
Upexi Inc 's trailing twelve months Revenue growth was higher than company's average 27.99% and higher than 57.81% growth in Mar 31 2026.

In the Consumer Non Cyclical sector 153 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 3215 to 3589.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry # 14
Consumer Non Cyclical Sector # 154
Overall # 3589

Revenue TTM Y/Y Growth Statistics
High Average Low
216.5 %
27.99 %
-70.58 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 14
Sector # 124
S&P 500 # 2991




Other Revenue Growth
Legal Cannabis Industry Revenue Growth Trends and Statistics
Consumer Non Cyclical Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
UPXI's Revenue Growth Ratio versus Legal Cannabis Industry, Consumer Non Cyclical Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue fall for the quarter ending Jun 30 2026 within Consumer Non Cyclical SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Tyson Foods Inc -0.12%$ -0.115 millions
Tootsie Roll Industries Inc-0.17%$ -0.171 millions
Ascend Wellness Holdings, Inc.-0.93%$ -0.932 millions
Andersons Inc -1.22%$ -1.218 millions
Scotts Miracle gro Co-1.34%$ -1.338 millions
Kraft Heinz Co-1.42%$ -1.417 millions
Willamette Valley Vineyards Inc -1.56%$ -1.564 millions
Post Holdings Inc -1.83%$ -1.829 millions
The Marzetti Company-2.19%$ -2.187 millions
Smithfield Foods Inc -2.30%$ -2.297 millions
Pilgrim s Pride Corporation-2.76%$ -2.755 millions
The Boston Beer Company Inc -3.34%$ -3.335 millions
Niagen Bioscience Inc -4.28%$ -4.281 millions
Mosaic Co-6.04%$ -6.042 millions
J and j Snack Foods Corp -6.19%$ -6.186 millions
Beyond Meat Inc -7.72%$ -7.721 millions
Central Garden and Pet Company-8.09%$ -8.088 millions
Golden Growers Cooperative-8.38%$ -8.378 millions
American Vanguard Corporation-9.17%$ -9.174 millions
Biote Corp -9.48%$ -9.478 millions
Vital Farms Inc -9.66%$ -9.660 millions
Trulieve Cannabis Corp.-10.31%$ -10.306 millions
Reed s Inc -14.98%$ -14.977 millions
Longevity Health Holdings Inc -21.37%$ -21.370 millions
Solesence Inc -22.87%$ -22.866 millions
Upexi Inc -26.57%$ -26.574 millions
Medifast Inc -27.01%$ -27.006 millions
The Hain Celestial Group Inc -27.60%$ -27.599 millions
22nd Century Group inc -29.86%$ -29.855 millions
Hydrofarm Holdings Group Inc -40.17%$ -40.169 millions


About Upexi Inc Revenue Growth Rates (UPXI), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Upexi Inc (CIK 1775194).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001477932-26-005668
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Upexi Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.